These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3633216)

  • 1. Large granular lymphocytes, Leu 7 reactivity and natural killer cell function in peripheral blood of patients with Hodgkin's disease.
    Berényi E; Surányi P; Pálóczi K; Szegedi G
    Cancer Immunol Immunother; 1986; 21(2):164-6. PubMed ID: 3633216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal T-lymphocyte function in patients with Hodgkin's disease in long-lasting remission.
    Lauria F; Raspadori D; Foà R; Tazzari PL; Lusso P; Fierro MT; Matera L; Baccarani M; Tura S
    Tumori; 1986 Feb; 72(1):75-80. PubMed ID: 2937189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
    Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
    Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal natural killer cell activity in Hodgkin's disease patients in remission.
    Douer D; Shaked N; Ramot B
    Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large granular lymphocytes from patients with expanded LGL populations acquire cytotoxic functions and release lymphokines upon in vitro activation.
    Pistoia V; Prasthofer EF; Tilden AB; Barton JC; Ferrarini M; Grossi CE; Zuckerman K
    Blood; 1986 Nov; 68(5):1095-100. PubMed ID: 3490286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
    Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
    J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The natural killer cell activity and count of large granule-containing lymphocytes in the blood of patients with malignant lymphomas].
    Zlochevskaia LL; Kindzel'skiĭ LP; Shabaeva MM; Tsyganok TV
    Vrach Delo; 1990 Feb; (2):36-9. PubMed ID: 2339548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
    Muhonen T; Teerenhovi L; Saksela E
    Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrastructural characteristics of NKHI+- and CD8+-subpopulations of large granule-containing lymphocytes in the blood of patients with Hodgkin's disease].
    Butenko AK; Khomenko BM
    Eksp Onkol; 1989; 11(5):56-9. PubMed ID: 2507273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis).
    Maggi E; Parronchi P; Del Prete G; Ricci M; Bosi A; Moretta L; Romagnani S
    J Immunol; 1986 Feb; 136(4):1516-20. PubMed ID: 3080527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient natural killer (NK) cells in paroxysmal nocturnal haemoglobinuria (PNH): studies of lymphoid cells fractionated by discontinuous density gradient centrifugation.
    Yoda Y; Abe T
    Br J Haematol; 1985 Aug; 60(4):669-75. PubMed ID: 4027193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
    Hercend T; Griffin JD; Bensussan A; Schmidt RE; Edson MA; Brennan A; Murray C; Daley JF; Schlossman SF; Ritz J
    J Clin Invest; 1985 Mar; 75(3):932-43. PubMed ID: 3884668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
    J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphoma.
    Healy F; Rees RC; Hancock BW
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):775-83. PubMed ID: 2412830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human natural killer cell-associated antigen defined by monoclonal antibody anti-Leu (NKP-15): functional and two-color flow cytometry analysis.
    Lanier LL; Phillips JH; Warner NL; Babcock GF
    J Leukoc Biol; 1984 Jan; 35(1):11-7. PubMed ID: 6608568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human K cells by surface antigens and morphology at the single cell level.
    Wåhlin B; Perlmann P
    J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
    Strauchen JA; Breakstone B
    Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy.
    Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.